Status:

COMPLETED

A Retrospective Non Interventional Study on First Line Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)

Lead Sponsor:

Pierre Fabre Medicament

Collaborating Sponsors:

Clinact

Conditions:

BRAF V600E Mutation Positive

Metastatic Colorectal Cancer

Eligibility:

All Genders

18+ years

Brief Summary

The presence of a BRAFV600E mutation is considered a marker of poor prognosis in patients with mCRC, and findings from clinical trials have largely remained inconclusive regarding the efficacy of firs...

Detailed Description

This retrospective, multi-center longitudinal study on BRAFV600E mutant mCRC patients will be conducted in Europe to characterize the first-line treatment patterns. All BRAFV600E mutant patients havin...

Eligibility Criteria

Inclusion

  • Diagnosis of histologically or cytologically confirmed CRC that is metastatic and unresectable
  • Presence of BRAFV600E mutation in tumor tissue, as confirmed by a local assay
  • Initiated first-line treatment with drugs registered for mCRC in the respective country at the time of treatment between January 1st, 2016 and December 31st, 2018 (both days inclusive)
  • Provision of informed consent or non-opposition to the patient (or next of kin, if applicable) for the use of data, according to local regulations

Exclusion

  • Patients will be excluded from the study if they fulfil any of the following criteria:
  • Patients with another concomitant cancer at the time of diagnosis\*
  • Patients participating in interventional trials on investigational drugs at the time of initiation of first-line treatment
  • Except for non-metastatic non-melanoma skin cancers, or in situ or benign neoplasms; a cancer will be considered concomitant if it occurs within 5 years of mCRC diagnosis.

Key Trial Info

Start Date :

April 12 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 12 2021

Estimated Enrollment :

274 Patients enrolled

Trial Details

Trial ID

NCT04317599

Start Date

April 12 2020

End Date

May 12 2021

Last Update

January 2 2026

Active Locations (34)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 9 (34 locations)

1

Barmherzige Brüder Krankenhaus St. Veit/Glan.

Saint Veit/Glan, Austria

2

Medizinische Universität Wien

Vienna, Austria

3

Imelda VZW

Bonheiden, Belgium

4

AZ Klina

Brasschaat, Belgium